The Worldwide AI In Cancer Diagnostics Market is Projected to reach USD 509 Million by 2028, at a CAGR of 28.6%
Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
AI In Cancer Diagnostics Market Growth, Trends and Report Highlights
According to a new report, published by KBV research, The Global AI In Cancer Diagnostics Market size is expected to reach $509 million by 2028, rising at a market growth of 28.6% CAGR during the forecast period.
The Hospital market is leading the Global AI In Cancer Diagnostics Market by End-user in 2021; thereby, achieving a market value of $295.6 million by 2028. It is due to the growing adoption of AI solutions in the hospital to address the dearth of healthcare workers and quick detection of cancer are the reason which propels the growth of the AI in cancer diagnostic market.
The Hardware market is experiencing a CAGR of 28.8% during (2022 - 2028). It is because the robots can patch the soft tissues completely safely and without harming other tissues. The robot’s ability to suture on the aircraft is 5 times more quickly than the surgeons whereas 9 times more rapid with the physicians utilizing the laparoscopic manual instrument. The new advanced Robotic surgeries include high-resolution 3D view, excellent real-time movement, and the abolishment of natural tremors from the body.
The Lung Cancer market is expected to witness a CAGR of 29.5% during (2022 - 2028). It is because lung cancer starts with the lungs later on it me transfer and might spread to lymph nodes to the brain. Moreover, cancer of the organs can be transmitted to the lungs. The process of cancer transfer in the various organs is known as metastases. Most lung cancers are of two primary subtypes that are recognized as non-small cell and small cell. The treatment of these cells depends on their size and the area of cancer.
The North America market dominated the Global AI In Cancer Diagnostics Market by Region in 2021; thereby, achieving a market value of $203.3 Million by 2028. The Europe market is poised to grow a CAGR of 28% during (2022 - 2028). Additionally, The Asia Pacific market would witness a CAGR of 29.6% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/ai-in-cancer-diagnostics-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Microsoft Corporation, Flatiron Health, Paige AI, Inc., PathAI, Inc., Therapixel, Tempus, Inc., SkinVision BV, Cancer Center Sp. z o.o., Medial EarlySign and Kheiron Medical Technologies Limited.
Global AI In Cancer Diagnostics Market Segmentation
By End-user
- Hospital
- Surgical Centers & Medical Institutes
- Others
By Component
- Software Solutions
- Hardware
- Services
By Cancer Type
- Breast Cancer
- Lung Cancer
- Brain Tumor
- Skin Cancer & Cervical Cancer
- Prostate & Colorectal Cancer
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Microsoft Corporation
- Flatiron Health
- Paige AI, Inc.
- PathAI, Inc.
- Therapixel
- Tempus, Inc.
- SkinVision BV
- Cancer Center Sp. z o.o.
- Medial EarlySign
- Kheiron Medical Technologies Limited
Related Reports:
North America AI In Cancer Diagnostics Market Size, Share, 2028
- November-2022
- 76 Pages
LAMEA AI In Cancer Diagnostics Market Size, Projection by 2028
- November-2022
- 86 Pages
Europe AI In Cancer Diagnostics Market Size & Share by 2028
- November-2022
- 86 Pages
Asia Pacific AI In Cancer Diagnostics Market Size & Share, 2028
- November-2022
- 86 Pages